Teva-Terbinafine

  • Generic name

    terbinafine hydrochloride

  • Brand reference

    Lamisil®

  • Strength

    250 mg

  • DIN

    02240346

  • Therapeutic class

    Currently not available

  • Therapeutic area

    Anti-Infectives

  • Package size

    Blister 28
    Bottle 100

  • Product code

    84383-0126
    84383-0040

  • UPC

    068510376268
    068510376404

  • Generic name:

    terbinafine hydrochloride

  • Brand reference:

    Lamisil®

  • Product code:

    84383-0126
    84383-0040

  • Strength

    250 mg

  • DIN

    02240346

  • UPC:

    068510376268
    068510376404

  • Therapeutic class

    Currently not available

  • Therapeutic area:

    Anti-Infectives

  • Package size:

    Blister 28
    Bottle 100

Composition

Active ingredient

terbinafine hydrochloride


Non-medicinal ingredients

colloidal silicon dioxide, croscarmellose sodium, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose.

Product characteristics

  • Dosage form

    tablet

  • Shape

    -

  • Marking 1

    -

  • Marking 2

    -

  • Colour

    -

  • Secondary colour

    -

  • Scored

    -

  • Flavour

    -

  • Gluten

    currently not available

  • Latex

    not applicable

Disclaimers

All information about raw materials and/or allergen information for Teva Canada’s products is obtained from our suppliers and/or third-party affiliates and is based on their records.

Please be advised that the Medical Information department is not always notified of change in third-party affiliates and/or change in suppliers of the active and inactive ingredients that may occur over time, and all information provided herein is based on our last records on file.

Our manufacturing sites are not certified gluten-free. Raw materials and finished products are not tested for the presence of gluten. Therefore, the presence of trace amounts of gluten in the raw materials and in the finished products cannot be excluded.

"Latex" refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging, or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process; however, this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and/or packaging facilities may be wearing latex gloves.

Product monograph/consumer information leaflet


View monograph

Notice

We are modifying our product names to align with our corporate name change. Accordingly, please expect product monographs to contain the “Novo-”, “ratio-”, “ACT”, "CO" prefix or the new “Teva” prefix. These prefixes may be used interchangeably on the website.

Should you have any questions about our product names or our corporate name change, please do not hesitate to contact us. Our Customer Care department can be reached at 1-800-268-4127 regarding your inquiry.